This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Children's Medical Center Corporation, Pfizer Corporation. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,077 
1 out of 4,490 
Years Active: 2023-2026
Title: Oleg V Kovalenko: Innovator in Antibody Development
Introduction
Oleg V Kovalenko is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Oleg V Kovalenko holds a patent for "CD1a antibodies and uses thereof." This patent involves antibodies and antigen-binding fragments that specifically bind to Cluster of Differentiation 1a (CD1a). The embodiments of this patent include various uses and associated methods for utilizing these antibodies and fragments in medical applications.
Career Highlights
Throughout his career, Oleg has worked with prominent organizations such as Pfizer Corporation and Children's Medical Center Corporation. His experience in these institutions has allowed him to contribute to significant advancements in medical research and development.
Collaborations
Oleg has collaborated with notable professionals in his field, including Florian E Winau and Chew Shun Chang. These collaborations have further enriched his work and expanded the impact of his innovations.
Conclusion
Oleg V Kovalenko's contributions to antibody development exemplify the vital role of inventors in advancing medical science. His patent on CD1a antibodies highlights the potential for innovative solutions in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile